These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 33982829)
1. Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines. Mitchell AP; Mishra A; Dey P; Curry MA; Trivedi NU; Haddadin M; Rahman MW; Winn AN; Dusetzina SB; Bach PB Oncologist; 2021 Sep; 26(9):771-778. PubMed ID: 33982829 [TBL] [Abstract][Full Text] [Related]
2. Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014-2017. Rahman MW; Trivedi NU; Bach PB; Mitchell AP J Natl Compr Canc Netw; 2021 Dec; 20(13):1-9. PubMed ID: 34965511 [TBL] [Abstract][Full Text] [Related]
3. Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors. Checketts JX; Sims MT; Vassar M JAMA Dermatol; 2017 Dec; 153(12):1229-1235. PubMed ID: 29049553 [TBL] [Abstract][Full Text] [Related]
4. Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology. Mitchell AP; Winn AN; Lund JL; Dusetzina SB Oncologist; 2019 May; 24(5):632-639. PubMed ID: 30728276 [TBL] [Abstract][Full Text] [Related]
5. Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines. Liu X; Tang LL; Mao YP; Liu Q; Sun Y; Chen L; Lin JC; Ma J Oncologist; 2019 Apr; 24(4):498-504. PubMed ID: 30459237 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan. Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027 [TBL] [Abstract][Full Text] [Related]
7. Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors. Mitchell AP; Basch EM; Dusetzina SB JAMA Oncol; 2016 Dec; 2(12):1628-1631. PubMed ID: 27561170 [TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis. Ozaki A; Saito H; Onoue Y; Sawano T; Shimada Y; Somekawa Y; Tsuji A; Tanimoto T BMJ Open; 2019 Sep; 9(9):e028805. PubMed ID: 31494604 [TBL] [Abstract][Full Text] [Related]
9. Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly available disclosures. Pokorny AMJ; Bero LA; Moynihan R; Mintzes BJ Intern Med J; 2021 Nov; 51(11):1816-1824. PubMed ID: 32744396 [TBL] [Abstract][Full Text] [Related]
10. Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan. Yamamoto K; Murayama A; Ozaki A; Saito H; Sawano T; Tanimoto T Int Urogynecol J; 2021 Feb; 32(2):443-451. PubMed ID: 33151353 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross-sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019. Kamamoto S; Murayama A; Kusumi E; Yoshida M; Saito H; Sawano T; Yamashita E; Tanimoto T; Ozaki A Pediatr Blood Cancer; 2022 Oct; 69(10):e29891. PubMed ID: 35949170 [TBL] [Abstract][Full Text] [Related]
12. Evaluating Financial Conflicts of Interest Among Contributors to Clinical Practice Guidelines of the American College of Obstetricians and Gynecologists. Wright MR; Frye L; Vo Solis L; Checketts JX; Guevara C; Smith L; Vassar M J Am Osteopath Assoc; 2020 Jul; 120(7):462-470. PubMed ID: 32598460 [TBL] [Abstract][Full Text] [Related]
13. Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study. Mooghali M; Glick L; Ramachandran R; Ross JS BMJ Open; 2023 Jan; 13(1):e069115. PubMed ID: 36690402 [TBL] [Abstract][Full Text] [Related]
14. [Financial contributions to guideline group members from industry: An analysis based on the US Open Payments database]. Anjos DRD; Eisch E; Mathes T Z Evid Fortbild Qual Gesundhwes; 2020 Aug; 153-154():39-43. PubMed ID: 32553895 [TBL] [Abstract][Full Text] [Related]
15. Financial Conflicts of Interest Among Authors of Urology Clinical Practice Guidelines. Carlisle A; Bowers A; Wayant C; Meyer C; Vassar M Eur Urol; 2018 Sep; 74(3):348-354. PubMed ID: 29747945 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines. Horn J; Checketts JX; Jawhar O; Vassar M JAMA Otolaryngol Head Neck Surg; 2018 Mar; 144(3):194-201. PubMed ID: 29270633 [TBL] [Abstract][Full Text] [Related]
17. Industry payments to US physicians for cancer therapeutics: An analysis of the 2016-2018 open payments datasets. Meyers DE; Chisamore TM; McInnes MDF; Gyawali B; Prasad V; Booth CM J Cancer Policy; 2021 Jun; 28():100283. PubMed ID: 35559912 [TBL] [Abstract][Full Text] [Related]
18. Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019. Tarras ES; Marshall DC; Rosenzweig K; Korenstein D; Chimonas S JAMA Oncol; 2021 Mar; 7(3):440-444. PubMed ID: 33377904 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Financial Conflicts of Interest Among Physician-Authors of American College of Rheumatology Clinical Practice Guidelines. Wayant C; Walters C; Zaaza Z; Gilstrap C; Combs T; Crow H; Vassar M Arthritis Rheumatol; 2020 Sep; 72(9):1427-1434. PubMed ID: 32039569 [TBL] [Abstract][Full Text] [Related]
20. Examination of Industry Payments to Radiation Oncologists in 2014 Using the Centers for Medicare and Medicaid Services Open Payments Database. Jairam V; Yu JB Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):19-26. PubMed ID: 26547386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]